GeneBio Systems
Anti-Flu A (H3N2) HA/Hemagglutinin Broadly Neutralizing Reference Antibody (CR8020)
Anti-Flu A (H3N2) HA/Hemagglutinin Broadly Neutralizing Reference Antibody (CR8020)
SKU:VK515096
Couldn't load pickup availability
Size:100ug
Description:CR8020 is a broadly neutralizing antibody (bNAb) targeting the stem region of influenza A virus (IAV) hemagglutinin (HA) and is in phase II trials for prophylactic use against group 2 IAVs. Structural and computational analyses show that CR8020 binds HA residues subject to antigenic drift and host selection pressure, with escape mutations observed in some H7N9 strains. Additionally, effective engagement of Fcγ receptors (FcγR) is crucial for antibody efficacy, but membrane steric hindrance may limit HA-CR8020-FcγR complex formation. These findings highlight epitope mutability and immune complex accessibility as key factors in bNAb development.
Host species:Human
Tested applications:
Species reactivity:Influenza A virus (strain A/Hong Kong/1/1968 H3N2)
Form:Liquid
Storage buffer:0.01M PBS, pH 7.4.
Purity:>95% purity as determined by SDS-PAGE.
Clonality:
Isotype:IgG1-lambda
Applications:ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target:Hemagglutinin, Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, HA
Purification:Protein A/G purified from cell culture supernatant.
Endotoxin level:Please contact us for this information.
Expression system:Mammalian Cells
Accession:Q91MA7
Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Reconstitution:
Background:
Alternative Names:
Clone ID:CR8020
Species:
Note:For research use only. Not suitable for clinical or therapeutic use.
